References
- Matthews KA, Meilahn E, Kuller LH, et al. Menopause and risk factors for coronary heart disease. N Engl J Med 1989; 321(10):641–6
- Poehlman ET, Toth MJ, Gardner AW. Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med 1995; 123(9):673–5
- Wing RR, Matthews KA, Kuller LH, et al. Weight gain at the time of menopause. Arch Intern Med 1991; 151 (1):97–102
- Denke MA, Sempos CT, Grundy SM. Excess body weight. An under-recognized contributor to dyslipidemia in white American women. Arch Intern Med 1994; 154(4):401–10
- Hjortland MC, McNamara PM, Kannel WB. Some atherogenic concomitants of menopause: The Framingham Study. Am J Epidemiol 1976; 103(3):304–11
- Lindquist O, Bengtsson C. Serum lipids, arterial blood pressure and body weight in relation to the menopause: results from a population study of women in Goteborg, Sweden. Scand J Clin Lab Invest 1980; 40(7):629–36
- Tchernof A, Poehlman ET. Effects of the menopause transition on body fatness and body fat distribution. Obes Res 1998; 6(3): 246–54
- Heymsfield SB, Gallagher D, Poehlman ET, et al. Menopausal changes in body composition and energy expenditure. Exp Gerontol 1994; 29(3–4):377–89
- McDowell MA, Briefel RR, Alaimo K, et al. Energy and macronutrient intakes of persons ages 2 months and over in the United States: Third National Health and Nutrition Examination Survey, Phase 1, 1988–91. Adv Data 1994(255):1–24
- Espeland MA, Stefanick ML, Kritz-Silverstein D, et al. Effect of postmenopausal hormone therapy on body weight and waist and hip girths. Postmenopausal Estrogen-Progestin Interventions Study Investigators. J Clin Endocrinol Metab 1997; 82(5):1549–56
- Kohrt WM, Malley MT, Dalsky GP, et al. Body composition of healthy sedentary and trained, young and older men and women. Med Sci Sports Exerc 1992; 24(7):832–7
- Kuller LH. Hormone replacement therapy and coronary heart disease: a new debate. Med Clin North Am 2000; 84(1): 181–98
- Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial. JAMA 1995; 273(3):199–208
- Haarbo J, Marslew U, Gotfredsen A, et al. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 1991; 40(12):1323–6
- Gambacciani M, Ciaponi M, Cappagli B, et al. Body weight, body fat distribution, and hormonal replacement therapy in early postmenopausal women. J Clin Endocrinol Metab 1997; 82(2):414–7
- Simkin-Silverman L, Wing RR, Hansen DH, et al. Prevention of cardiovascular risk factor elevations in healthy premenopausal women. Prev Med 1995; 24(5):509–17
- Simkin-Silverman LR, Wing RR, Boraz MA, et al. Maintenance of cardiovascular risk factor changes among middle-aged women in a lifestyle intervention trial. Women's Health 1998; 4(3):255–71
- Simkin-Silverman LR, Wing RR, Boraz MA, et al. A randomized clinical trial of weight gain prevention in 535 healthy women during menopause. Circulation 1999; 100(18):I–238(Supplement I)
- Simkin-Silverman LR, Wing RR. Management of obesity in primary care. Obes Res 1997; 5(6):603–12
- Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults—The Evidence Report. National Institutes of Health. Obes Res 1998; 6 Suppl 2:51S–209S